Personalized Nutritional Formula for ICU Patients: A Study on Prognosis and Multidimensional Health Markers

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorChinese Medical Association

About this trial

This study aims to evaluate the effects of an individualized enteral nutrition formula on clinical outcomes in critically ill adult patients in the intensive care unit (ICU). Participants will be randomly assigned to one of two groups: the individualized nutrition group or the standard nutrition group. In the individualized group, the total daily amount of enteral nutrition will be calculated and adjusted daily based on the patient's resting energy expenditure (measured by indirect calorimetry) and serum protein levels. In the standard group, a fixed-dose formula will be administered according to routine clinical protocols recommended by current guidelines. The intervention will be initiated within 48 hours of ICU admission and continued for up to 14 days or until ICU discharge. The study will assess clinical prognosis, as well as changes in gut and pulmonary microbiota, serum metabolomics, and macronutrient balance. The findings may provide evidence for personalized nutrition strategies in critically ill patients.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

None

Disqualifiers

None

Trial design

Design model

Parallel

Treatments tested in this trial

  • Individualized Enteral Nutrition Formula

    Dietary supplement

    Individualized Enteral Nutrition Formula Based on Daily Metabolic Measurements

  • Standard Enteral Nutrition Formula

    Dietary supplement

    Standardized enteral nutrition formula will be administered according to the routine clinical protocol recommended by current guidelines.

Treatment groups

1,200 Participants
are divided into 2 treatment groups
Group A: Individualized Nutrition GroupExperimental treatment 1 intervention
Group B: Standard Nutrition GroupActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Length of ICU Stay

Total number of days from ICU admission to ICU discharge.

Time frame
Up to 90 days

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: